Long-term stress with hyperglucocorticoidemiainduced hepatic steatosis with VLDL overproduction is dependent on both 5-HT2 receptor and 5-HT synthesis in liver

International Journal of Biological Sciences

Volumn 12, Issue 2, 2016, Pages 219-234

  Fu, Jihua ^a   Ma, Shaoxin ^a   Li, Xin ^a   An, Shanshan ^a   Li, Tao ^a   Guo, Keke ^a   Lin, Min ^a   Qu, Wei ^a   Wang, Shanshan ^a   Dong, Xinyue ^a   Han, Xiaoyu ^a   Fu, Ting ^a   Huang, Xinping ^a   Wang, Tianying ^a   He, Siyu ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

5 hydroxytryptamine 2A, 2B receptor (5 HT2A2BRs); 5 hydroxytryptamine synthesis; Long term stress; Triglycerides (TGs) synthesis; Very low density lipoprotein (VLDL) assembly

Indexed keywords

FATTY ACID; GLUCOCORTICOID; SEROTONIN; SEROTONIN 2 RECEPTOR; TRYPTOPHAN HYDROXYLASE; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; BLOOD; CELL CULTURE; FATTY LIVER; GENE SILENCING; GENETICS; HEP-G2 CELL LINE; HUMAN; LIVER; MALE; METABOLISM; PHYSIOLOGICAL STRESS; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; CELLS, CULTURED; CHOLESTEROL, VLDL; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; GENE SILENCING; GLUCOCORTICOIDS; HEP G2 CELLS; HUMANS; LIVER; MALE; MODELS, BIOLOGICAL; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TRYPTOPHAN HYDROXYLASE; UP-REGULATION;

EID: 84956945323     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.13062     Document Type: Article

References (47)

1. Tecott LH. Serotonin and the orchestration of energy balance. Cell metabolism. 2007; 6: 352-61.
2. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annual review of medicine. 2009; 60: 355-66.
3. Lesurtel M, Soll C, Graf R, Clavien PA. Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives. Cellular and molecular life sciences : CMLS. 2008; 65: 940-52.
4. Nocito A, Dahm F, Jochum W, Jang JH, Georgiev P, Bader M, et al. Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis. Gastroenterology. 2007; 133: 608-18.
5. Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, Kurrer M, et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nature medicine. 2008; 14: 756-61.
6. Osawa Y, Kanamori H, Seki E, Hoshi M, Ohtaki H, Yasuda Y, et al. L-tryptophan-mediated enhancement of susceptibility to nonalcoholic fatty liver disease is dependent on the mammalian target of rapamycin. The Journal of biological chemistry. 2011; 286: 34800-8.
7. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacology, biochemistry, and behavior. 2002; 71: 533-54.
8. Kroeze WK, Kristiansen K, Roth BL. Molecular biology of serotonin receptors structure and function at the molecular level. Current topics in medicinal chemistry. 2002; 2: 507-28.
9. Li Q, Hosaka T, Harada N, Nakaya Y, Funaki M. Activation of Akt through 5-HT2A receptor ameliorates serotonin-induced degradation of insulin receptor substrate-1 in adipocytes. Molecular and cellular endocrinology. 2013; 365: 25-35.
10. Sumara G, Sumara O, Kim JK, Karsenty G. Gut-derived serotonin is a multifunctional determinant to fasting adaptation. Cell metabolism. 2012; 16: 588-600.
11. Mo B, Feng N, Renner K, Forster G. Restraint stress increases serotonin release in the central nucleus of the amygdala via activation of corticotropin-releasing factor receptors. Brain research bulletin. 2008; 76: 493-8.
12. McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain research. 2000; 886: 172-89.
13. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology. 2005; 30: 1-10.
14. Yuen EY, Zhong P, Li X, Wei J, Yan Z. Restoration of glutamatergic transmission by dopamine D4 receptors in stressed animals. The Journal of biological chemistry. 2013; 288: 26112-20.
15. Seglen PO. Preparation of isolated rat liver cells. Methods in cell biology. 1976; 13: 29-83.
16. Haffner SM, Kennedy E, Gonzalez C, Stern MP, Miettinen H. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes care. 1996; 19: 1138-41.
17. Wendel AA, Cooper DE, Ilkayeva OR, Muoio DM, Coleman RA. Glycerol-3-phosphate acyltransferase (GPAT)-1, but not GPAT4, incorporates newly synthesized fatty acids into triacylglycerol and diminishes fatty acid oxidation. The Journal of biological chemistry. 2013; 288: 27299-306.
18. Foufelle F, Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c. Biochem J. 2002; 366: 377-91.
19. Fisher EA, Pan M, Chen X, Wu X, Wang H, Jamil H, et al. The triple threat to nascent apolipoprotein B. Evidence for multiple, distinct degradative pathways. The Journal of biological chemistry. 2001; 276: 27855-63.
20. Geer EB, Islam J, Buettner C. Mechanisms of glucocorticoid-induced insulin resistance: focus on adipose tissue function and lipid metabolism. Endocrinology and metabolism clinics of North America. 2014; 43: 75-102.
21. Amat J, Baratta MV, Paul E, Bland ST, Watkins LR, Maier SF. Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nature neuroscience. 2005; 8: 365-71.
22. Li Q, Hosaka T, Shikama Y, Bando Y, Kosugi C, Kataoka N, et al. Heparin-binding EGF-like growth factor (HB-EGF) mediates 5-HT-induced insulin resistance through activation of EGF receptor-ERK1/2-mTOR pathway. Endocrinology. 2012; 153: 56-68.
23. Barahona M-J, Sucunza N, Resmini E, Fernandez-Real J-M, Ricart W, Moreno-Navarrete J-Ma, et al. Persistent body fat mass and inflammatory marker increases after long-term cure of Cushing’s syndrome. The Journal of Clinical Endocrinology & Metabolism. 2009; 94: 3365-71.
24. Campbell JE, Peckett AJ, D'souza AM, Hawke TJ, Riddell MC. Adipogenic and lipolytic effects of chronic glucocorticoid exposure. American Journal of Physiology-Cell Physiology. 2011; 300: C198-C209.
25. Slavin B, Ong J, Kern P. Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. Journal of lipid research. 1994; 35: 1535-41.
26. Villena JA, Roy S, Sarkadi-Nagy E, Kim K-H, Sul HS. Desnutrin, an Adipocyte Gene Encoding a Novel Patatin Domain-containing Protein, Is Induced by Fasting and Glucocorticoids ECTOPIC EXPRESSION OF DESNUTRIN INCREASES TRIGLYCERIDE HYDROLYSIS. Journal of Biological Chemistry. 2004; 279: 47066-75.
27. Krsek M, Rosicka M, Nedvidkova J, Hana V, Marek J, Haluzík M, et al. Increased lipolysis of subcutaneous abdominal adipose tissue and altered noradrenergic activity in patients with Cushings syndrome: an in vivo microdialysis study. Physiological research. 2006; 55: 421.
28. Lim S, Son KR, Song IC, Park HS, Jin CJ, Jang HC, et al. Fat in liver/muscle correlates more strongly with insulin sensitivity in rats than abdominal fat. Obesity (Silver Spring, Md). 2009; 17: 188-95.
29. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proceedings of the National Academy of Sciences of the United States of America. 2009; 106: 15430-5.
30. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, et al. Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography. European journal of endocrinology / European Federation of Endocrine Societies. 2003; 149: 543-8.
31. Dourakis SP, Sevastianos VA, Kaliopi P. Acute severe steatohepatitis related to prednisolone therapy. The American journal of gastroenterology. 2002; 97: 1074-5.
32. Nanki T, Koike R, Miyasaka N. Subacute severe steatohepatitis during prednisolone therapy for systemic lupus erythematosis. The American journal of gastroenterology. 1999; 94: 3379.
33. Dolinsky VW, Douglas DN, Lehner R, Vance DE. Regulation of the enzymes of hepatic microsomal triacylglycerol lipolysis and re-esterification by the glucocorticoid dexamethasone. The Biochemical journal. 2004; 378: 967-74.
34. Amatruda JM, Danahy SA, Chang CL. The effects of glucocorticoids on insulin-stimulated lipogenesis in primary cultures of rat hepatocytes. Biochem J. 1983; 212: 135-41.
35. Zhao LF, Iwasaki Y, Zhe W, Nishiyama M, Taguchi T, Tsugita M, et al. Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. Endocrine journal. 2010; 57: 317-24.
36. Schwarz J-M, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. The American Journal of Clinical Nutrition. 2003; 77: 43-50.
37. Kling A, Mjörndal T, Rantapää-Dahlqvist S. Glucocorticoid treatment increases density of serotonin 5-HT2 A receptors in humans. Psychoneuroendocrinology. 2013; 38: 1014-20.
38. Clark MS, Russo AF. Tissue-specific glucocorticoid regulation of tryptophan hydroxylase mRNA levels. Molecular brain research. 1997; 48: 346-54.
39. Crane JD, Palanivel R, Mottillo EP, Bujak AL, Wang H, Ford RJ, et al. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nature medicine. 2015; 21: 166-72.
40. Kamagate A, Qu S, Perdomo G, Su D, Kim DH, Slusher S, et al. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice. The Journal of clinical investigation. 2008; 118: 2347-64.
41. Armario A. The hypothalamic-pituitary-adrenal axis: what can it tell us about stressors? CNS & neurological disorders drug targets. 2006; 5: 485-501.
42. Blundell JE, Lawton CL, Halford JC. Serotonin, eating behavior, and fat intake. Obesity research. 1995; 3 Suppl 4: 471S-6S.
43. Laplante M, Sabatini DM. An emerging role of mTOR in lipid biosynthesis. Current biology : CB. 2009; 19: R1046-52.
44. Khamzina L, Veilleux A, Bergeron S, Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology. 2005; 146: 1473-81.
45. Li S, Brown MS, Goldstein JL. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107: 3441-6.
46. Chang GR, Chiu YS, Wu YY, Chen WY, Liao JW, Chao TH, et al. Rapamycin protects against high fat diet-induced obesity in C57BL/6J mice. Journal of pharmacological sciences. 2009; 109: 496-503.
47. Takishita E, Takahashi A, Harada N, Yamato M, Yoshizumi M, Nakaya Y. Effect of sarpogrelate hydrochloride, a 5-HT2 blocker, on insulin resistance in Otsuka Long-Evans Tokushima fatty rats (OLETF rats), a type 2 diabetic rat model. Journal of cardiovascular pharmacology. 2004; 43: 266-70.